Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: J Thromb Thrombolysis. 2013 Feb;35(2):209–222. doi: 10.1007/s11239-012-0812-9

Table 2.

Dosing and timing of clopidogrel–naïve patients

Subject Clopidogrel dose Timing of dose in relation to 1st blood draw
P4-012 600 mg 42 min after
P4-022 600 mg 2 min before
P4-031 600 mg 173 min after
P4-045 300 mg 80 min after
P4-046 300 mg 149 min after
P4-047 Unknown dose Post-procedurea
P4-048 600 mg 18 min before
P4-050 300 mg 32 min after
P4-054 600 mg 6 min before
P4-055 600 mg 36 min after
P4-056 600 mg 28 min after
P4-057 600 mg 31 min after
P4-058 600 mg 38 min after

Eight of the patients were categorized as clopidogrel naïve as they received the loading dose of clopidogrel (either 300 or 600 mg of clopidogrel) at the end of the intervention after the post bivalirudin blood draw. Six of the patients were categorized as clopidogrel-naïve as they received the loading dose within 35 min of the timing of sampling for the first blood draw

a

Details of the timing or dose of clopidogrel not available, but patient did receive clopidogrel post-procedurally. The patients classified as being on clopidogrel, were on chronic clopidogrel having received clopidogrel daily for at least 7 days prior to presentation